Dashboard
Poor Management Efficiency with a low ROE of 2.66%
- The company has been able to generate a Return on Equity (avg) of 2.66% signifying low profitability per unit of shareholders funds
Stock is technically in a Bearish range
With ROE of 10.3, it has a Expensive valuation with a 0.7 Price to Book Value
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
Ravinder Heights for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ravinder Heights Ltd is Rated Sell
Ravinder Heights Ltd is rated Sell by MarketsMOJO. This rating was last updated on 04 Feb 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read More
Ravinder Heights Ltd is Rated Sell
Ravinder Heights Ltd is rated Sell by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial data presented here reflect the stock’s current position as of 26 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Ravinder Heights Ltd is Rated Sell
Ravinder Heights Ltd is rated Sell by MarketsMOJO. This rating was last updated on 04 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 15 April 2026, providing investors with the latest perspective on the company’s position.
Read More Announcements 
Clarification Sought Under Regulation 30 For Significant Movement In Price
12-Jun-2026 | Source : BSEClarification sought under Regulation 30 for significant movement in Price
Clarification sought from Ravinder Heights Ltd
11-Jun-2026 | Source : BSEThe Exchange has sought clarification from Ravinder Heights Ltd on June 11 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Compliances-Reg.24(A)-Annual Secretarial Compliance
30-May-2026 | Source : BSEPlease find enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sunanda Jain (74.74%)
Serum Institute Of India Pvt Ltd (4.34%)
16.62%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is -99.95% vs -63.62% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -123.56% vs -68.70% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 18,280.00% vs -6.25% in Sep 2024
Growth in half year ended Sep 2025 is 8,472.34% vs -135.00% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 16,979.55% vs -6.38% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 3,299.38% vs 11.96% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 13,085.96% vs -8.06% in Mar 2025
YoY Growth in year ended Mar 2026 is 2,024.80% vs -18.14% in Mar 2025